Dosimetric optimization and clinical feasibility of the block technique in helical tomotherapy for bilateral breast cancer.
기술보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
21 patients with BBC without distant metastasis, who underwent initial radiotherapy from January 2021 to September 2024, were retrospectively analyzed.
I · Intervention 중재 / 시술
initial radiotherapy from January 2021 to September 2024, were retrospectively analyzed
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Lung and spinal CB maximized cardiopulmonary and spinal cord dose reductions at the expense of prolonging the BOT and MU. DB could be an alternative strategy for patients requiring a shorter BOT.
In this study, we aimed to investigate the effects of different block combinations in helical tomotherapy (HT) on the dose distribution in the target volume, protection of the organs at risk (OARs), a
- p-value p < 0.01
APA
Zhu L, He Q, et al. (2026). Dosimetric optimization and clinical feasibility of the block technique in helical tomotherapy for bilateral breast cancer.. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. https://doi.org/10.1016/j.meddos.2026.01.005
MLA
Zhu L, et al.. "Dosimetric optimization and clinical feasibility of the block technique in helical tomotherapy for bilateral breast cancer.." Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 2026.
PMID
41741302
Abstract 한글 요약
In this study, we aimed to investigate the effects of different block combinations in helical tomotherapy (HT) on the dose distribution in the target volume, protection of the organs at risk (OARs), and treatment efficiency in patients with bilateral breast cancer (BBC), and to provide a dosimetric basis for the selection of individualized radiotherapy plans. Clinical data of 21 patients with BBC without distant metastasis, who underwent initial radiotherapy from January 2021 to September 2024, were retrospectively analyzed. Based on the properties of blocks-complete block (CB), directional block (DB), no block (NB) and their positions: spinal cord and bilateral lungs, 5 block combination plans were designed for each patient: SNLN (spinal NB/lung NB), SCLN (spinal CB/ lung NB), SCLC (spinal CB/lung CB), SNLC (spinal NB/lung CB), SDLD (spinal DB/lung DB). The dosimetric parameters for the target and OARs, treatment plan monitor units (MUs), and beam-on times (BOTs) were compared. All 5 plans met the clinical requirements for the target, V, V, homogeneity index, and conformity index with no statistically significant difference (p > 0.05). The lung CB significantly reduced the heart and lung irradiation doses. The spinal CB reduced the maximum dose to the spinal cord in the supraclavicular lymph node drainage area from 25 to 35 Gy to 4-9 Gy (p < 0.01). The lung CB group (Plans SCLC,SNLC) increased the BOT by 35% (p < 0.01) and MU by 2596 to 3060 compared to the lung NB group (Plans SNLN,SCLN). The DB (Plan SDLD) group balanced the OAR sparing and treatment efficiency; cardiopulmonary doses in the DB group were between those in the lung CB and NB groups (p < 0.01). The HT block technique significantly enhanced OAR protection. Lung and spinal CB maximized cardiopulmonary and spinal cord dose reductions at the expense of prolonging the BOT and MU. DB could be an alternative strategy for patients requiring a shorter BOT.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- Botulinum toxin A injection using ultrasound combined with balloon guidance for the treatment of cricopharyngeal dysphagia: analysis of 21 cases.
- Reduced capsular contracture with smooth and textured breast implants following submuscular mammoplasty: systematic literature review.
- Development of glucagon-like Peptide-1 lysosomal targeting chimeras for degradation of extracellular and membrane proteins.
- Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer.
- DNA Hypermethylation Suppresses Thyroid Peroxidase Expression and May Be a Promising Diagnostic Marker for Thyroid Cancer.